SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- On September 10, 2025, Lifisher, a leading pioneer in helping Chinese brands expand globally, marked its 20th...
Launch of AI Agent Development Platform 3.0, available internationally via Tencent Cloud, at the 2025 Global Digital Ecosystem Summit Tencent Cloud's overseas client...